This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Acquisition Of Ebix, Inc. By An Affiliate Of Goldman, Sachs & Co. May Not Be In The Best Interests Of Ebix Shareholders

SAN DIEGO and ATLANTA, May 2, 2013 /PRNewswire/ --  Shareholder rights attorneys at Robbins Arroyo LLP are investigating the acquisition of Ebix, Inc. (NASDAQ: EBIX) by Goldman, Sachs & Co. On May 1, 2013, Ebix announced that it had entered into a definitive merger agreement whereby Ebix shareholders will receive $20.00 in cash for each share.


The Board of Directors' Actions May Prevent Ebix Shareholders from Receiving Maximum Value for Their Stock

Robbins Arroyo LLP's investigation focuses on whether the board of directors at Ebix is undertaking a fair process to obtain maximum value and adequately compensate its shareholders in the merger or whether they are seeking to benefit themselves.

The $20.00 merger consideration represents a premium of only 7.47% based on Ebix's closing price on April 30, 2013, the last trading day prior to the merger announcement.  The 7.4% premium is substantially below the median premium of 35.47% for comparable transactions over the past three years.  Further, the $20.00 offer price is substantially below the target price of $25.00 set by an analyst at BOE Securities on September 13, 2012, and a target price of $24.00 set by an analyst at Craig-Hallum on March 13, 2013. 

Is the Acquisition Best for Ebix and Its Shareholders?

On March 14, 2013, Ebix released its 2012 financial results reflecting record revenue growth.  Specifically, Ebix reported fourth quarter revenue of $54.0 million an increase of 22.6% as compared to the same quarter 2011.  Further, Ebix reported full year revenue increased to $199.4, an 18% increase over 2011.  Moreover, earnings per share for the fourth quarter 2012 increased 9%, to $0.48 per share.  In announcing these results, Robin Raina, Ebix's Chairman, President, and CEO, stated, "The Company's 2012 results reflect the strength of Ebix's core business that helped us deliver outstanding results in one of the most challenging years for the insurance industry in a decade.  Our revenue, operating cash flow, liquidity and diluted EPS were all at record levels as we look forward to continued high levels of performance in 2013."

Given these facts, the firm is examining the board of directors' decision to sell Ebix now rather than allow shareholders to continue to participate in the company's continued success and future growth prospects.   

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs